Epitomee Med (EPIT) Stock Statistics & Valuation Metrics

Epitomee Med has a market cap or net worth of 200.68M. The enterprise value is ―.

Epitomee Med has 30,068,865 shares outstanding. The number of shares has decreased by -2.65% in one year.

Epitomee Med’s return on equity (ROE) is -0.16 and return on invested capital (ROIC) is -18.01%.

The current PE Ratio of Epitomee Med is 121.4. Epitomee Med’s PEG ratio is 9.89.

In the last 12 months, Epitomee Med had revenue of 0.00 and earned -5.32M in profits. Earnings per share was -0.18.

In the last 12 months, operating cash flow was -28.38M and capital expenditures -17.59M, giving a free cash flow of -45.97M billion.

Epitomee Med pays an annual dividend of ―, resulting in a dividend yield of ―

Epitomee Med upcoming earnings date is ―, ―.

Epitomee Med as a current ratio of 9.00, with Debt / Equity ratio of 14.62%

In the past 12 months, Epitomee Med has paid 0.00 in taxes.

Epitomee Med EV to EBITDA ratio is -46.11, with an EV/FCF ratio of -20.52.

Epitomee Med has 18.28M in cash and marketable securities with 6.53M in debt, giving a net cash position of 11.75M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Epitomee Med is ―, which is 11.43% higher than the current price. The consensus rating is ―